Skip to main content


Kiefer Ahn specializes in economic analysis to support litigation and complex business matters. As an intellectual property economist, he focuses on issues such as patent damages and antitrust in the pharmaceutical and life sciences industry.


Dr. Ahn has advised policymakers and business leaders on pharmaceutical drug pricing as well as forecasting cost projections. He also conducts research on a wide range of topics related to intellectual property and healthcare markets.

Prior to joining NERA, Dr. Ahn served as an economist in the US Congress (Energy and Commerce Committee) and the Johns Hopkins Drug Access and Affordability Initiative. He is actively engaged in academic research and publishes in peer-reviewed journals


  • PhD in health economics, Johns Hopkins University
  • MS in health policy and economics, Cornell University
  • BS in policy analysis and management, Cornell University


  • Korean